Publication

Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.

Journal Paper/Review - Apr 18, 2022

Units
PubMed
Doi
Contact

Citation
Furrer K, Weder W, Eboulet E, Betticher D, Pless M, Stupp R, Krueger T, Perentes J, Schmid R, Lardinois D, Furrer M, Früh M, Peters S, Curioni-Fontecedro A, Stahel R, Rothschild S, Hayoz S, Opitz I. Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment. J Thorac Cardiovasc Surg 2022; 164:1587-1602.e5.
Type
Journal Paper/Review (English)
Journal
J Thorac Cardiovasc Surg 2022; 164
Publication Date
Apr 18, 2022
Issn Electronic
1097-685X
Pages
1587-1602.e5
Brief description/objective

Surgical treatment of locally advanced non-small cell lung cancer including single or multilevel N2 remains a matter of debate. Several trials demonstrate that selected patients benefit from surgery if R0 resection is achieved. We aimed to assess resectability and outcome of patients with locally advanced clinical T3/T4 (American Joint Committee on Cancer 8 edition) tumors after induction treatment followed by surgery in a pooled analysis of 3 prospective multicenter trials.